{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftheidi.simplecast.com%2Fepisodes%2Fpolitics-and-prescription-drugs-whats-ahead-in-2024-vb3uA_yK","width":444,"version":"1.0","type":"rich","title":"Politics and Prescription Drugs: What's Ahead in 2024","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/9660dd78-6154-402f-87c9-4f85da5cd51a/0d2a0f98-2268-4f07-93dc-0f411170596e/masthead-square-the-idi.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/0d23c1da-18c8-443b-bb30-0a9c6eaab81e\" height=\"200\" width=\"100%\" title=\"Politics and Prescription Drugs: What&apos;s Ahead in 2024\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"2024 is just a month away; what will the new year hold for pharma and market access? Everything is up for grabs -- from the fate of the Inflation Reduction Act to the White House. Al Jackson of Valuate joins the IDI to explain what's a stake."}